These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27180415)

  • 1. Testing and Treating HCV in Arkansas.
    Patil N
    J Ark Med Soc; 2016 Apr; 112(12):220. PubMed ID: 27180415
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C update: implications of the blood transfusion "lookback".
    Younossi ZM; Canuto PE
    Cleve Clin J Med; 1998 Sep; 65(8):412-5, 418-22. PubMed ID: 9769562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV and HCV testing for young drug users in Rhode Island.
    Pugatch D; Anderson BJ; O'Connell JV; Elson LC; Stein MD
    J Adolesc Health; 2006 Mar; 38(3):302-4. PubMed ID: 16488833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
    Falade-Nwulia O; Mehta SH; Lasola J; Latkin C; Niculescu A; O'Connor C; Chaulk P; Ghanem K; Page KR; Sulkowski MS; Thomas DL
    J Viral Hepat; 2016 May; 23(5):366-74. PubMed ID: 26840570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.
    Sulkowski MS; Thomas DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S263-9. PubMed ID: 15768333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV screening.
    Smyth BP; McMahon J; O'Connor JJ; Ryan J
    Ir Med J; 2000; 93(5):154-5. PubMed ID: 11072928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users].
    Gyarmathy VA; Rácz J
    Orv Hetil; 2011 Jan; 152(4):124-30. PubMed ID: 21224188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.
    Perlman DC; Jordan AE
    Int J Drug Policy; 2015 Feb; 26(2):217-9. PubMed ID: 25465345
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus: Prevention, screening, and interpretation of assays.
    Albeldawi M; Ruiz-Rodriguez E; Carey WD
    Cleve Clin J Med; 2010 Sep; 77(9):616-26. PubMed ID: 20810872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus seroprevalence: selected health care settings in Texas.
    Melville SK; Heseltine G; Delamater E; Gilani Z; Hendricks K; Suarez L
    Tex Med; 2006 Mar; 102(3):56-61. PubMed ID: 17115588
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience at the Val de Marne/Essonne network].
    Bastie A
    Soins; 1999 Dec; (641):41-3. PubMed ID: 10857438
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for hepatitis C in injecting and ex-injecting drug users in North East Essex.
    Bishton E; Oluboyede F; Grylls E; Woods L; Thomas S
    Public Health; 2014 Nov; 128(11):1036-8. PubMed ID: 25443107
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C: who is at risk and how do we identify them?
    Goldberg D; Anderson E
    J Viral Hepat; 2004 Sep; 11 Suppl 1():12-8. PubMed ID: 15357858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities to address the hepatitis C epidemic in the correctional setting.
    Boutwell AE; Allen SA; Rich JD
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
    Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
    Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provision of bloodborne virus screening in substance misuse.
    Harniman B
    Nurs Times; 2006 Aug 1-7; 102(31):28-30. PubMed ID: 16913519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors related to screening of hepatitis C virus in general medicine].
    Rotily M; Loubière S; Prudhomme J; Portal I; Tran A; Hofliger P; Valla D; Moatti JP
    Gastroenterol Clin Biol; 2002 Mar; 26(3):261-9. PubMed ID: 11981471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis C among a juvenile detention population.
    Feldman GM; Sorvillo F; Cole B; Lawrence WA; Mares R
    J Adolesc Health; 2004 Dec; 35(6):505-8. PubMed ID: 15581531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.